Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...

The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...

NEW YORK – Thermo Fisher Scientific, Genovation Health, and XYGene have signed a multiyear comarketing collaboration agreement aimed at expanding access to integrated genomic solutions, the firms ...

Join us for an insightful webinar on the use of polygenic risk scores (PRS) for cardiovascular disease (CVD). The analysis of genetic variation across large populations plays a crucial role in ...

SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

Across a multitude of genomic assays, scientists begin with sample collection. Whether their analyte is destined for genotyping, microarrays, or high throughput sequencing, researchers can benefit ...

Unlike external plant traits, the naked human eye cannot distinguish the genotypes that comprise the underlying genetic material responsible for these phenotypic traits. To make genotypes accessible ...